IRIS
MINICUCCI, LAURA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 7.115
AS - Asia 11
Totale 7.126
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 7.115
CN - Cina 7
VN - Vietnam 4
Totale 7.126
Salva come PNG Salva come JPEG
Città #
Genova 4.300
Genoa 1.567
Rapallo 727
Vado Ligure 497
Bordighera 24
Beijing 5
Ho Chi Minh City 2
Bình Dương 1
Quảng Ngãi 1
Totale 7.124
Salva come PNG Salva come JPEG
Nome #
Abnormal activation of calpain and protein kinase Cα promotes a constitutive release of matrix metalloproteinase 9 in peripheral blood mononuclear cells from cystic fibrosis patients 212
Evidence for alteration of calpain/calpastatin system in PBMC of cystic fibrosis patients 178
Calpain inhibition promotes the rescue of F(508)del-CFTR in PBMC from cystic fibrosis patients. 175
Phenotype/Genotype Correlation and Cystic Fibrosis Related Diabetes Mellitus (Italian Multicenter Study) 163
Pathological role of the calpain/calpastatin system in cystic fibrosis 157
Impact of inhaled corticosteroids on the risk of early Pseudomonas Aeruginosa acquisition in cystic fibrosis 152
Diabetes mellitus after kidney transplantation in pediatric recipients 151
Caregiver burden and vocational participation among parents of adolescents with CF 151
Younger age at diagnosis of Type 1 diabetes mellitus in children of immigrated families born in Italy. 150
Epidemiology and clinical course of Burkholderia cepacia complex infections, particularly those caused by different Burkholderia cenocepacia strains, among patients attending an italian Cystic Fibrosis Center 150
Discharge report accuracy 146
Antimicrobial use and Pseudomonas Aeruginosa susceptibility profile in a cystic fibrosis centre 141
FùPhenotype-genotype correlation and cystic fibrosis related diabetes (CFRD) 140
Blood Ketone bodies in patients with recent-onset type 1 diabetes (a multicenter study) 140
Home nebulizer use and bacterial colonization in cystic fibrosis. 140
High incidence of childhood type 1 diabetes in Liguria, Italy, from 1989 to 1998 139
Discrepancy between sensitization to inhaled allergens and respiratory symptoms in pediatric patients with type 1 diabetes mellitus. 139
The calpain-calpastatin system in cystic fibrosis: physiopathological implications 137
Alcaligenes xylosoxidans ed evoluzione della lesione polmonare in fibrosi cistica. 131
Validation of a predictive survival model in Italian patients with cystic fibrosis 131
Alta incidenza di diabete di tipo 1 in Liguria nel periodo 1989-1998 128
Lumacaftor-ivacaftor in patients with cystic fibrosis homozygous for phe508del CFTR 127
Vitamin D receptor polymorphisms: are they really associated with type 1 diabetes? 122
N1303K MUTATION AND DIABETES MELLITUS IN CYSTIC FIBROSIS. 122
Controlled clinical study on the activity of a new mucoregulating drug in obstructive bronchial pathology with a marked hypersecretory feature. The pediatric experience. 120
Investigation of risk factors associated with different HLA genotypes of susceptibility to Type 1 diabetes (The DIABFIN Project). 118
Pharmacokinetics of high-dose extended-infusion meropenem during pulmonary exacerbation in adult cystic fibrosis patients: a case series 118
Length of gestation and gender are associated with HLA genotypes at risk for Type 1 diabetes (Italian DIABFIN 3). 117
Beta-cell autoantibodies and diabetes mellitus family history in cystic fibrosis 116
Oxidative stress and antioxidant therapy in cystic fibrosis. 116
A polymorphism in the 5' UTR of the DEFB1 gene is associated with the lung phenotype in F508del homozygous Italian cystic fibrosis patients Clin Chem Lab Med. 2011 Jan;49(1):49-54. 114
Impact of the A (H1N1) pandemic influenza (season 2009-2010) on patients with cystic fibrosis. 114
Beclometasone dipropionato per aerosol versus budesonide per turbohaler nella broncopneumopatia della fibrosi cistica. 113
Testing two different doses of tiotropium Respimat® in cystic fibrosis: phase 2 randomized trial results. 110
Slow-release insulin in cystic fibrosis patients with glucose intolerance: a randomized clinical trial. 110
Role of home therapy with ofloxacin in patients with cystic fibrosis (CF) 108
Cystic Fibrosis - Related diabetes mellitus 103
Oral hypoglycemic agents in Cystic Fibrosis related diabetes (CFRD) 100
Identification of novel WFS1 mutations in Italian children with Wolfram Syndrome 98
Liver disease as risk factor for cystic fibrosis-related diabetes development 96
Emergenze diabetologiche: chetoacidosi diabetica 94
Identificazione di neonati a rischio genetico di diabete tipo 1 (DM1) da avviare a prevenzione primaria (studio PREVEFIN) - Dati preliminari 92
Elevata incidenza del diabete mellito di tipo 1 in Liguria dal 1989 al 1998 90
When should hyperglycemia be treated in cystic fibrosis? 90
Programmi svolti dalla II Clinica Pediatrica. 89
Characterization of Staphylococcus aureus small colony variant strains isolated from Italian patients attending a regional cystic fibrosis care centre. 88
Terapia cortisteroidea inalatoria nella broncopneumopatia della fibrosi cistica: confronto tra beclometasone dipropionato per aerosol e budesonide per turbohaler. 85
Early antibiotic treatment for Pseudomonas aeruginosa eradication in patients with cystic fibrosis: a randomised multicentre study comparing two different protocols. 85
Ursodeoxycholic Acid for Liver Disease Associated with Cystic Fibrosis: A Double-Rlind Multifiter Trial 82
Marker immunologici di diabete di tipo 1 in fibrosi cistica. 81
Ruolo di alcaligenes xylodoxidans nella broncopneumopatia cronica in fibrosi cistica. 80
Nuove mutazioni del gene della wolframina in tre casi pediatrici 79
Prima descrizione italiana di una nuova mutazione nel gene HNF-1beta (MODY 5) 76
The use of ofloxacin in cystic fibrosis patients. 75
Screening for type 1 diabetes genetic rIsk in newborns of continental Italy. Primary prevention (Prevefin Italy) - preliminary data 74
Il Diabete in Fibrosi cistica 72
Study of efficacy of piperacillin in the treatment of severe infections of the child and of the young adult 71
”Punteggi di valutazione clinica nella Fibrosi Cistica”. 71
The significance of 2-thiol-propionamido-acetic acid in the treatment of cystic fibrosis. 70
The adolescent with type 1 diabetes mellitus. 70
Usefulness of blood ketone bodies for monitoring insulin therapy in patients with recent onset type 1 diabetes (a multicenter study). 66
Rheological Properties of Cystic Fibrosis Bronchial Secretion and in Vitro Drug Permeation Study: The Effect of Sodium Bicarbonate 61
MODY e diabete non autoimmune. 57
Indagini per le funzioni epatobiliari 57
Totale 7.148
Salva come PNG Salva come JPEG
Categoria #
all - tutte 21.600
article - articoli 15.229
book - libri 0
conference - conferenze 5.379
curatela - curatele 0
other - altro 227
patent - brevetti 0
selected - selezionate 0
volume - volumi 765
Totale 43.200
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021246 0 0 0 24 14 30 18 29 32 30 25 44
2021/2022729 9 49 55 104 20 43 56 195 18 66 21 93
2022/2023862 76 63 11 136 118 177 0 55 141 9 73 3
2023/2024427 22 51 4 52 38 114 4 33 18 8 26 57
2024/20251.100 65 116 36 83 93 127 75 180 35 42 111 137
2025/2026437 252 38 57 90 0 0 0 0 0 0 0 0
Totale 7.148